Soluble programmed death-ligand 1 as a prognostic biomarker for overall survival in patients with diffuse large B-cell lymphoma: a replication study and combined analysis of 508 patients
Delphine Rossille(Inserm), Imane Azzaoui(Inserm), Andrew L. Feldman(Mayo Clinic in Arizona), Matthew J. Maurer(Mayo Clinic in Florida), Gaëlle Labouré, Marie Parrens, Céline Pangault(Inserm), Thomas M. Habermann(Mayo Clinic in Arizona), S. Ansell(Mayo Clinic in Arizona), Brian K. Link(University of Iowa), Karin Tarte(Inserm), T. E. Witzig(Mayo Clinic in Arizona), Thierry Lamy(Inserm), Susan L. Slager(Mayo Clinic in Florida), Mikaël Roussel(Inserm), Nöel Milpied, James R. Cerhan(Mayo Clinic in Florida), Thierry Fest(Inserm)
Cited by 44Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis